Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis
- 1 June 2004
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (12) , 835-842
- https://doi.org/10.1016/j.amjmed.2004.02.028
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Systematic review of celecoxib for osteoarthritis and rheumatoid arthritisBMJ, 2003
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patientGastroenterology, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Nonsteroidal anti-inflammatory drug gastropathyGastroenterology, 2000
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- 10 Economics of osteoarthritis: a global perspectiveBailliere's Clinical Rheumatology, 1997
- Nonsteroidal antiinflammatory drugs and dyspepsia in the elderlyDigestive Diseases and Sciences, 1995
- Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly PersonsAnnals of Internal Medicine, 1988